Opiant Pharmaceuticals, Inc.
OPNTDelisted Mar 2, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001385508
Opiant Pharmaceuticals, Inc. was delisted on Mar 2, 2023; its insiders filed their last Form 4 on Mar 3, 2023; 37 institutions reported holding it in 13F filings for Q4 2022, worth $43.2M in total; no superinvestor held it.
Q3 2021 vs. Q2 2021
How the institutions holding Opiant Pharmaceuticals, Inc. changed between Q2 2021 and Q3 2021.
All holders in Q3 2021All holders in Q2 2021
| Measure | Q2 2021 | Q3 2021 | Change |
|---|---|---|---|
| Holders | 26 | 35 | +9 |
| Shares | 877.8K | 1.27M | +391.9K (+44.6%) |
| Value | $11.8M | $32.7M | +$20.9M (+177.8%) |
New holders (9)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q3 2021 but not at the end of Q2 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Advisers, LP | 83,100 | $2.14M | 0.01% |
| EAM Investors, LLC | 69,046 | $1.78M | 0.30% |
| Two Sigma Investments, LP | 51,045 | $1.31M | 0.00% |
| Parkman Healthcare Partners LLC | 30,000 | $772.0K | 0.20% |
| Essex Investment Management Co LLC | 24,792 | $638.0K | 0.08% |
| Bailard, Inc. | 16,242 | $418.0K | 0.01% |
| Federated Hermes, Inc. | 63 | $2.00K | 0.00% |
| O'Shaughnessy Asset Management, LLC | 41 | $1.00K | 0.00% |
| Sage Private Wealth Group, LLC | 5 | $0 | 0.00% |
Sold out (0)
Institutions that held Opiant Pharmaceuticals, Inc. at the end of Q2 2021 and filed for Q3 2021 without it.
None.